- Research article
- Open Access
- Open Peer Review
Supplementation of fresh ucche (Momordica charantia L. var. muricata Willd) prevented oxidative stress, fibrosis and hepatic damage in CCl4 treated rats
- Abu Taher Sagor†1,
- Mohammed Riaz Hasan Chowdhury†1,
- Nabila Tabassum1,
- Hemayet Hossain2,
- Md Mahbubur Rahman1 and
- Md Ashraful Alam1Email author
© Sagor et al.; licensee BioMed Central. 2015
- Received: 3 November 2014
- Accepted: 26 March 2015
- Published: 11 April 2015
Ucche (Momordica charantia L. var. muricata (Willd.) Chakravarty) has been reported to possess many benefits and medicinal properties. However, the protective effect of ucche against carbon tetrachloride (CCl4) induced hepatotoxicity have not been clarified fully yet. The aim of the present study was to investigate the effects of ucche on oxidative stress and inflammation in liver of CCl4 treated rats.
Female Long Evans rats were administered with CCl4 orally (1 ml/kg) twice a week for 2 weeks and were supplemented with freshly prepared crashed ucche (10% wt/wt of diet) with powdered chaw food. Both plasma and liver tissues were analyzed for AST, ALT and ALP activities. Oxidative stress parameters were measure by determining malondialdehyde (MDA), nitric oxide (NO), advanced protein oxidation product (APOP), and reduced glutathione (GSH) concentrations and catalase activities in plasma and liver tissues. Moreover, inflammation and tissue fibrosis were confirmed by histological staining of liver tissue sections.
Our data suggest that ucche significantly prevented CCl4-induced hepatotoxicity, indicated by both diagnostic indicators of liver damage (serum transferases activities) and histopathological analysis. Moreover, CCl4 administration induced profound elevation of reactive oxygen species (ROS) production and oxidative stress, as evidenced by increasing lipid peroxidation level and depletion of antioxidant enzymes in liver. Fresh ucche supplementation prevented the oxidative stresses and improved antioxidant enzyme function. Furthermore, fresh ucche supplementation reduced hepatic inflammatory cell infiltration, iron deposition and fibrosis in liver of CCl4 treated rats.
In conclusion, these results suggested that the inhibition of CCl4-induced inflammation by ucche is due at least in part to its anti-oxidant activity and its ability to modulate the inflammation and fibrosis in liver.
- Momordica charantia
- Reactive oxygen species
- Oxidative stress
Liver is the main organ for nutrition metabolism and detoxifying foreign chemical agents in living animals. Other functions of liver are helping digestion, production of invaluable endogenous hormones, enzymes as well as production of glucose while fasting. However, hepatic dysfunctions like cirrhosis, steatosis, hepatitis as well as drug induced hepatic damages are increasing day by day . Oxidative stress has been proposed to be increased in most cases of liver dysfunction mentioned above. Carbon tetrachloride (CCl4) is a well known hepatotoxin used extensively for the study hepatotoxicity in animal models. CCl4 stimulates bio-activation of the phase I cytochrome P450 system to form reactive metabolic trichloromethyl radicals (•CCl3) and peroxy trichloromethyl radicals (•OOCCl3) . These peroxy radicals stimulate kupffer cells to produce ROS, such as •O2−, H2O2 and •OH, which thus causes lipid peroxidation and reported to induce acute and chronic tissue injuries [3,4]. Free radicals generated by CCl4 are thus responsible for the membrane disintegration of hepatocytes which subsequently release marker enzymes of hepatotoxicity such as aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) . Centrilobular necrosis and steatosis are also commonly seen in CCl4- induced liver toxicities [5,6]. Inflammation and fibrosis are some other early events which may also occur during the progression of the liver damage due to CCl4 challenge [7,8].
Bitter melon (Momordica charantia) is a culinary bitter vegetable commonly used in traditional dishes in Bangladesh and Indian subcontinent . Bitter melon can be found in different shapes and sizes. Generally, two varieties of bitter melon are found, mainly karela (Momordica charantia L. var. charantia C. B. Clarke) and ucche (Momordica charantia L. var. muricata (Willd.) Chakravarty). Karela is 20–30 cm long, oblong with bluntly tapering ends and pale green in color, while ucche is only 6–10 cm in length and has a narrower shape with pointed ends, and a dark green surface covered with jagged, triangular “teeth” and ridges. Both varieties are also used as a traditional medicine for the treatment of diabetes and other stomach complaints in Bangladesh. Recent evidences suggest that Momordica charantia extract may improve insulin resistance  and lowers plasma lipid profile in diabetic and obese experimental animals [11,12]. Momordica charantia extract also improved antioxidant status and prevents oxidative stress in vivo . Several bioactive molecules were isolated from Momordica charantia leaves, fruits and seeds [14-17]. Gallic acid, tannic acid, (+)-catechin, caffeic acid, p-coumaric, gentisic acid, chlorogenic acid, and epicatechin have been isolated from various parts of Momordica charantia plants . Moreover, cucurbitane type triterpenoids such as charantin, kuguacins, momordicin, and karavilagenins were also isolated from Momordica charantia . The extract also showed antioxidant activities in various experimental models . However, karela variety is extensively studied in most scientific research reported to date, whereas ucche variety is less explored for any proper scientific evaluation. Thus, the current study was undertaken to evaluate the therapeutic benefit of ucche in oxidative stress, inflammation, fibrosis and liver damage induced by CCl4 treated rats.
Plant material and preparation of extracts
Momordica charantia fruits were purchased from a local vegetable market in Dhaka, Bangladesh. This plant has been identified by the expert Mr. Sarker Nasir Uddin, Senior Scientific Officer, of National Herberium, Mirpur, Dhaka Bangladesh and a voucher specimen was deposited (Acc No. 40566) for future reference. Fresh fruits (250 g) were taken and cut into small pieces and macerated in electrical blander without adding any water. This suspension was used as a supplementation to add with powder food (10% W/W of diet).
Animals and treatment
Ten to twelve weeks old, 24 Long Evans female rats (150–210 g) were obtained from Animal production unit of Animal House at Department of Pharmaceutical Sciences, North South University and were kept in individual cages at room temperature of 25 ± 3°C with a 12 h dark/light cycles. They have free access to standard laboratory feed (Pellet food was crushed to powder) and water, according to the study protocol approved by Ethical Committee of Department of Pharmaceutical Sciences, North South University for animal care and experimentation. To study the hepatoprotective effects of Ucche, rats were equally divided into four groups (six rats each): Group I (Control), Group II (Control + Ucche), Group III (CCl4) and Group IV (CCl4 + Ucche). Animals of group I and II were treated with 1 ml/kg of saline (0.85%) and olive oil (1 ml/kg) intragastrically twice a week for two weeks. Rats of group II were supplanted with Ucche fruit in powder food (10% of powder food, w/w). Rats of group III and IV were treated with CCl4 (1:3 in olive oil) at a dose of 1 ml/kg intragastrically twice a week for two weeks. Animals of group III received only CCl4 treatment; however, animals of group IV received ucche fruit crashed in powder food (10% of powder food, w/w) along with CCl4 treatment. Animals were checked for the body weight, food and water intake on a daily basis. After 14 days all animals were weighted, sacrificed, collected the blood and all internal organs such as heart, kidney, spleen and liver. Immediately after collection of the organs, they were weighted and stored in neutral buffered formalin (pH 7.4) for histological analysis and in refrigerator at −20°C for further studies. Collected blood was centrifuged at 8000 rpm and separated the plasma and stored in refrigerator at −20°C for further analysis.
Assessment of hepatotoxicity
Liver marker enzymes (alanine aminotransferase (ALT), aspartate aminotransferase (AST), and alkaline phosphatase (ALP) were estimated in plasma by using Diatech diagnostic kits (Hungary) according to the manufacturers protocol.
Preparation of tissue sample for the assessment of oxidative stress markers
For determination of oxidative stress markers, liver tissue was homogenized in 10 volumes of Phosphate buffer containing (pH 7.4) and centrifuged at 12,000 × g for 30 min at 4°C. The supernatant was collected and used for the determination of protein and enzymatic studies as described below.
Estimation of lipid peroxidation
Lipid peroxidation in liver was estimated colorimetrically measuring malondialdehyde (MDA) followed by previously described method . In brief, 0.1 ml of tissue homogenate (Tris–HCl buffer, pH 7.5) was treated with 2 ml of (1:1:1 ratio) TBA-TCA-HCl reagent (thiobarbituric acid 0.37%, 0.25 N HCl and 15% TCA) and placed in hot water bath for 15 min and cooled. The absorbance of clear supernatant was measured against reference blank at 535 nm.
Estimation of nitric oxide (NO)
Nitric oxide (NO) was determined according to the method described by Tracy et al. as nitrate and nitrite . In this study, Griess-Illosvoy reagent was modified by using naphthyl ethylene diamine dihydrochloride (0.1% w/v) instead of 1-napthylamine (5%). The reaction mixture (3 mL) containing brain homogenates (2 mL) and phosphate buffer saline (0.5 mL) was incubated at 25°C for 150 min. A pink colored chromophore was formed which was measured at 540 nm against the corresponding blank solutions with a spectrophotometer. NO level was calculated as nitrate by using Sodium nitrate standard curve and expressed as nmol/mL.
Estimation of Advanced protein oxidation products (APOP)
APOP level was performed using previously described method reported by Witko-Sarsat  and Tiwari . Two mL of plasma was diluted (1:5) in PBS, 0.1 mL potassium iodide (1.16 M) was then added to each tube, followed by 0.2 mL acetic acid after 2 min. The absorbance of the reaction mixture was immediately read at 340 nm against a blank containing 2 mL of PBS, 0.1 mL of KI, and 0.2 mL of acetic acid. The chloramine-T absorbance at 340 nm was found linear within the range of 0 to 100 nmol/mL, APOP concentrations were expressed as nmol · mL−1 chloramine-T equivalents.
Estimation of catalase (CAT) activity
CAT activities were determined using previously described method [24,25] with some modifications. The reaction solution of CAT activities contained: 2.5 ml of 50 mmol phosphate buffer (pH 5.0), 0.4 ml of 5.9 mmol H2O2 and 0.1 ml enzyme extract. Changes in absorbance of the reaction solution at 240 nm were determined after one minute. One unit of CAT activity was defined as an absorbance change of 0.01 as units/min.
Estimation of reduced glutathione (GSH)
Reduced glutathione was estimated by the method of Jollow et al. . The total volume of 3.0 ml assay mixture composed of 0.1 ml filtered aliquot, 2.7 ml phosphate buffer (0.1 M, pH 7.4) and 0.2 ml DTNB (5,5-dithiobis-2-nitrobenzoic acid), (100 mM). The yellow color of the mixture was developed, read immediately at 412 nm on a Smart SpecTM plus Spectrophotometer and expressed as ng/mg protein.
For microscopic evaluation liver tissues were fixed in neutral buffered formalin and embedded in paraffin, sectioned at 5 μm and subsequently stained with hematoxylin/eosin to see the architecture of hepatic tissue and inflammatory cell infiltration. Sirious red staining for fibrosis and prussiun blue staining for iron deposition were also done in liver sections. Sections were then studied and photographed under light microscope (Zeiss Axioscope) at 40X magnifications.
All values are expressed as mean ± standard error of mean (SEM). The results were evaluated by using the Two way or One-way ANOVA followed by Bonferroni test using Graph Pad Prism Software, version 6. Statistical significance was considered p < 0.05 in all cases.
Effect on body weight, food and water intake
Effect on organ wet weight
Effect of bitter melon (Ucche) on body weight, food and water intake and organ weight of CCl 4 treated rats
Control + Ucche
CCl4 + Ucche
Initial Body weight
144.15 ± 4.65
146.93 ± 4.51
155.67 ± 7.13
133.14 ± 3.19
Final Body weight
175.83 ± 1.90
147.00 ± 3.81
146.68 ± 8.33
133.90 ± 5.89
17.8 ± 0.64
14.75 ± 0.60
11.08 ± 0.46
16.74 ± 0.81
20.58 ± 0.77
16.94 ± 0.89
11.80 ± 0.41
13.72 ± 0.54
Liver wet weight
6.09 ± 0.36
5.25 ± 0.10
5.62 ± 0.25
4.93 ± 0.47
Kidney wet weight
1.04 ± 0.07
0.95 ± 0.03
0.86 ± 0.04
0.71 ± 0.19
Heart wet weight
0.42 ± 0.02
0.46 ± 0.01
0.52 ± 0.01
0.45 ± 0.05
Spleen wet weight
0.49 ± 0.06
0.58 ± 0.02
0.81 ± 0.09
0.58 ± 0.04
Effect on biochemical parameter of liver functions
Effect of bitter melon (ucche) on biochemical parameter in plasma and liver
Control + Ucche
CCl4 + Ucche
19.0 ± 1.6
21.32 ± 1.68
37.9 ± 3.1
23.3 ± 4.0
13.8 ± 1.7
16.59 ± 2.62
30.5 ± 3.1
18.7 ± 1.9
50.8 ± 3.3
50.92 ± 2.76
81.2 ± 6.1
63.9 ± 4.7
6.34 ± 0.37
3.57 ± 0.54
7.7 ± 0.91
6.71 ± 0.77
3.22 ± 0.27
2.24 ± 0.22
5.8 ± 0.3
1.15 ± 0.32
APOP (nmol/mL equivalent to Chloramine-T)
82.60 ± 8.49
67.0 ± 9.2
164.4 ± 15.15
84.3 ± 8.8
6.00 ± 0.32
4.28 ± 0.38
2.93 ± 0.60
5.07 ± 0.74
GSH (ng/mg protein)
20.05 ± 1.81
18.39 ± 1.03
12.72 ± 0.57
16.39 ± 0.57
36.18 ± 3.22
31.01 ± 3.46
65.18 ± 3.87
46.51 ± 2.11
26.00 ± 3.88
34.67 ± 2.24
77.61 ± 4.80
28.77 ± 1.49
30.33 ± 3.67
31.42 ± 3.54
113.53 ± 3.71
68.25 ± 3.67
15.87 ± 1.56
20.21 ± 0.45
35.62 ± 4.21
18.11 ± 2.17
21.85 ± 1.86
24.62 ± 4.88
57.16 ± 6.44
36.92 ± 1.98
APOP (nmol/mL equivalent to Chloramine-T)
365.00 ± 40.19
450.0 ± 75.83
1357.62 ± 91.06
977.50 ± 63.05
52.13 ± 4.02
68.40 ± 5.92
26.32 ± 3.82
50.27 ± 2.33
GSH (ng/mg protein)
21.22 ± 1.91
19.22 ± 1.13
45.98 ± 5.05
32.89 ± 1.79
Oxidative stress markers and antioxidant enzymes
To determine the oxidative stress in our study, we evaluated the MDA, nitric oxide and APOP content in plasma and liver homogenates. CCl4 induced rats showed a higher concentration of lipid peroxidation product MDA both in plasma and liver homogenates (Table 2) (7.7 ± 0.91 and 57.16 ± 6.44 nmol/mL in plasma and liver homogenates respectively). Additionally, ucche (10% per kg of diet) co-treatment significantly reduced the level of lipid peroxides compared to CCl4 intoxicated group (6.71 ± 0.77 and 36.92 ± 1.98 nmol/mL in plasma and liver homogenates respectively); however, lipid peroxide level was still higher than the control.
CCl4 have profound effect on APOP development in plasma and liver. CCl4 challenge significantly increased the APOP concentration in plasma and liver (164.4 ± 15.15 and 1357.62 ± 91.06 nmol/mL equivalent to Chloramine-T respectively) which was decreased due to ucche (10% per kg of diet) supplementation in CCl4 intoxicated rats (84.3 ± 8.8 and 977.50 ± 63.05 nmol/mL equivalent to Chloramine-T respectively).
Nitric oxide measured as nitrate was also increased both in plasma and liver homogenates (5.8 ± 0.3 and 35.62 ± 4.21 nmol/mL in plasma and liver homogenates respectively) compared to control rats which was normalized by ramipril treatment in CCl4 intoxicated group (Table 2). CCl4 induced a significant decrease in liver antioxidant enzyme activities GSH and CAT respectively, compared to the control levels. In addition, CCl4 induced a significant increase in lipid peroxide level by more than four folds compared with the control group (Table 2). Treatment of animals with ucche (10% per kg of diet) concomitantly to CCl4 significantly counteracted the oxidative stress effect of CCl4. It was found that, the level of GSH and CAT activity restored near normal compared to CCl4 intoxicated group (Table 2).
Inflammation, fibrosis iron deposition in liver
Liver is one of the vital organs in our body responsible for detoxification of toxic chemicals and drugs. Chronic liver diseases are increasing in recent years and the medical treatments for these diseases are usually difficult to handle and showed limited efficacy. Therefore, it is necessary to find new alternative treatment for the management of liver diseases. CCl4 treatment is one of the most used methods for the study of experimental hepatic dysfunction nowadays; however, CCl4 is considered as an extremely toxic chemical agent . Several important basic mechanisms involving of tissue damages induced by CCl4 have been proposed, such as reactive free radical metabolites, lipid peroxidation, metabolic activation, covalent binding and disturbance of calcium homeostasis . The present study demonstrates that fresh ucche supplementation prevented oxidative stress, lowered inflammatory cell infiltration and fibrosis in liver and improved the hepatic enzymes function against CCl4-induced liver injury in rats.
Oxidative stress is the major cause of tissue damage in CCl4 treated animal model of hepatic dysfunction. CCl4 is metabolized by liver cytochrome P450 and converted into the free radical •CCl3 [28,29]. The free radical attacks hepatocytes and causes necrosis of parenchymal cells. We found that the concentration of MDA and APOP, which are indices of oxidative stress, were elevated in CCl4-challenged rats. However, decreased concentrations of these two compounds were found in plasma and the liver tissues of those CCl4-rats that were treated with ucche supplementation, which suggests that fresh ucche can effectively protect against lipid peroxidation and protein oxidation. Similar results were also reported by other investigators that fruit extract (300 mg/kg) and the plant extract at a dose of 5 ml/kg also produced significant protection of liver damage by preventing elevated TBARS and hydroperoxides concentration and increased the levels of glutathione peroxidase (GPx), superoxide dismutase (SOD), catalase and reduced glutathione in ammonium chloride-induced toxicity in rats [13,30]. Catalase is an important antioxidant enzymes responsible for the scavenging of free radical generated in tissue. Catalase enzyme exists in all aerobic cells, is a hemeprotein that metabolizes the H2O2 to form oxygen and water. Szymonik-Lesiuk et al. reported that CCl4 intoxication leads to changes in antioxidant enzymes activity . In our study, CCl4 treatment causes breakdown of catalase mediated prevention of tissue damage and lowered the catalase activity which was further improved to near normal by ucche supplementation. Oxidative stress mediated tissue damage also increases the liver marker enzyme activities. Damage to the liver typically results in leakage of AST and ALT into the bloodstream . In the present study CCl4 administration to rats caused a significant increase in serum AST, ALT and ALP activity which were further normalized by ucche supplementation. Nitric oxide is another mediator of oxidative stress despite of its valuable role in the maintenance of vascular tone and as signaling molecule. However, excess production of nitric oxide by iNOS may lead to hepatic injury which can be reversed by scavenging of nitric oxide [33,34]. Ucche supplementation also reduces the elevated nitrate concentration in plasma and tissues of CCl4 treated rats. Our results are also comparable to Chaudhari et al. who reported that hydroalcoholic extract of the plant leaves (100 and 200 mg/kg) normalized the levels of SGOT, SGPT, ALP, total bilirubin and prevented steatosis, centrilobular necrosis and vacuolization in liver of carbon tetrachloride induced liver damage in rats . Similar findings were also reported in another study that investigated the hepatoprotective effects of plant bioactive compounds against CCl4-induced injury in rats hepatocytes .
Moreover, oxidative stress mediated tissue damage may trigger inflammation and fibrosis in liver of CCl4 treated rats. Liver fibrosis is also characterized by a distortion of liver tissue architecture and an excessive deposition of extra cellular matrix (ECM) proteins that type I collagen predominates . Hepatic stellate cells (HSCs) have been recognized as the main matrix-producing cells in the process of liver fibrosis. Kupffer cells (KCs) could activate HSCs by producing and releasing a variety of mediators, such as proinflammatory cytokines and reactive oxygen species that fulfill a crucial function in the inflammatory responses of the liver . Histological examination also demonstrated that a large number of inflammatory cells infiltrated into the intralobular and interlobular regions together with increased collagen fibers in CCl4 treated rats compared with normal rats. On the contrary, ucche supplementation remarkably reduced the immigration of inflammatory cells and the deposition of collagen fibers compared with rats in model group treated with CCl4.
Another key finding in our model is the deposition of iron in hepatic tissues assessed through histologically by iron staining. Iron deposition is characteristics of many forms of liver diseases including viral hepatitis-C, alcoholic and nonalcoholic hepatitis [38,39]. In hepatic diseases, the Kupffer cells (KC) and liver cells are not capable of processing the iron due to heam oxygenase deficiency and deposited in the tissue which further contributes to oxidative tissue damage by fenton reaction [40-42]. Previous authors also reported that iron overload can enhance the development of liver cirrhosis in animal models [43,44]. Clinical evidence also noted that iron-loaded livers of hemochromatosis patients were also found to exhibit oxidative stress and enhanced expression of TGF-β1 . TGF-β1 is the key regulatory growth factor secreted by fibroblast cells due to activation by inflammatory stimuli and oxidative stress . Thus, the deposited iron can also accelerate the advancement of liver fibrosis by increasing α1-(I)-collagen mRNA expression . In our study, ucche supplementation significantly reduced the iron deposition and fibrosis in liver of rats treated with CCl4 further confirmed the reduction of oxidative stress in liver.
Phenolic or polyphenolic compounds are potent antioxidants and are capable of preventing oxidative stress in various diseases including liver damage . Previous reports suggest that various phenolic compounds such as gallic acid, tannic acid, (+)-catechin, caffeic acid, p-coumaric, gentisic acid, chlorogenic acid, and epicatechin are present in Momordica charantia plants [14,15]. Our analysis (unpublished data) on ucche fruit extract showed that ellagic acid and myricetin are present in abundant amount. Ellagic acid showed preventive effect in isoniazid-rifampicin induced liver damage  and cisplatin-induced oxidative stress in liver . Myricetin are also effective in lowering plasma lipids (which is one of the mechanism of hepatic protection in non alcoholic fatty liver like diseases), in high fat diet fed animals . However, it is not possible to speculate which phenolic compound responsible for the preventive activity in liver showed by ucche supplementation in this study, probably a combined effects of all phenolic compounds play their role and gave a synergistic effect.
In conclusion, our findings revealed that ucche supplementation has a protective effect against CCl4 induced hepatotoxicity. The hepatoprotective effects of ucche supplementation are likely related to the prevention of oxidative stress by increasing antioxidant activity, lowering lipid peroxidation, and improving the function of liver cells. Moreover, ucche supplementation also promotes hepatic protection by decreasing inflammation and fibrosis probably mediated by inhibiting iron mediated signaling pathways and HSCs activation. Further studies are needed to investigate the molecular mechanism of the hepatoprotective effect of ucche supplementation in CCl4 treated rats.
Authors gratefully acknowledge the logistic support provided by Department of Pharmaceutical Sciences, North South University Bangladesh.
- Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 2003;349(5):474–85.View ArticlePubMedGoogle Scholar
- Weber LWD, Boll M, Stampfl A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol. 2003;33(2):105–36.View ArticlePubMedGoogle Scholar
- Zhu W, Fung PC. The roles played by crucial free radicals like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CCl4-induced acute liver injury of mice. Free Radic Biol Med. 2000;29(9):870–80.View ArticlePubMedGoogle Scholar
- He SX, Luo JY, Wang YP, Wang YL, Fu H, Xu JL, et al. Effects of extract from Ginkgo biloba on carbon tetrachloride-induced liver injury in rats. World J Gastroenterol. 2006;12(24):3924–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Singh N, Kamath V, Narasimhamurthy K, Rajini PS. Protective effect of potato peel extract against carbon tetrachloride-induced liver injury in rats. Environ Toxicol Pharmacol. 2008;26(2):241–6.View ArticlePubMedGoogle Scholar
- Ai G, Liu Q, Hua W, Huang Z, Wang D. Hepatoprotective evaluation of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic: in vitro and in vivo studies. J Ethnopharmacol. 2013;146(3):794–802.View ArticlePubMedGoogle Scholar
- Cohen-Naftaly M, Friedman SL. Current status of novel antifibrotic therapies in patients with chronic liver disease. Therap Adv Gastroenterol. 2011;4(6):391–417.View ArticlePubMedPubMed CentralGoogle Scholar
- Reichenbach V, Ros J, FernÃ¡ndez-Varo G, Casals G, Melgar-Lesmes P, Campos T, et al. Prevention of fibrosis progression in CCl4-treated rats: role of the hepatic endocannabinoid and apelin systems. J Pharmacol Exp Ther. 2011;340(3):629–37.View ArticlePubMedGoogle Scholar
- Krawinkel MB, Keding GB. Bitter gourd (Momordica charantia): a dietary approach to hyperglycemia. Nutri Rev. 2006;64(7):331–7.View ArticleGoogle Scholar
- Shih C-C, Lin C-H, Lin W-L, Wu J-B. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats. J Ethnopharmacol. 2009;123(1):82–90.View ArticlePubMedGoogle Scholar
- Matsui S, Yamane T, Takita T, Oishi Y, Kobayashi-Hattori K. The hypocholesterolemic activity of Momordica charantia fruit is mediated by the altered cholesterol- and bile acid–regulating gene expression in rat liver. Nutri Res. 2013;33:580–5.View ArticleGoogle Scholar
- Shih C-C, Shlau M-T, Lin C-H, Wu J-B. Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice. Phytother Res. 2014;28(3):363–71.View ArticlePubMedGoogle Scholar
- Thenmozhi AJ, Subramanian P. Antioxidant potential of Momordica Charantia in ammonium chloride-induced hyperammonemic rats. Evidence-Based Complement Alternat Med. 2011, Article ID 612023.Google Scholar
- Kubola J, Siriamornpun S. Phenolic contents and antioxidant activities of bitter gourd (Momordica charantia L.) leaf, stem and fruit fraction extracts in vitro. Food Chem. 2008;110(4):881–90.View ArticlePubMedGoogle Scholar
- Horax R, Hettiarachchy N, Islam S. Total phenolic contents and phenolic acid constituents in 4 varieties of bitter melons (Momordica charantia) and antioxidant activities of their extracts. J Food Sci. 2005;70(4):C275–80.View ArticleGoogle Scholar
- Horax R, Hettiarachchy N, Chen P. Extraction, quantification, and antioxidant activities of phenolics from pericarp and seeds of bitter melons (Momordica charantia) harvested at three maturity stages (immature, mature, and ripe). J Agric Food Chem. 2010;58(7):4428–33.View ArticlePubMedGoogle Scholar
- Nakamura S, Murakami T, Nakamura J, Kobayashi H, Matsuda H, Yoshikawa M. Structures of new cucurbitane-type triterpenes and glycosides, karavilagenins and karavilosides, from the dried fruit of Momordica charantia L. in Sri Lanka. Chem Pharm Bull. 2006;54(11):1545–50.View ArticlePubMedGoogle Scholar
- Alam MA, Uddin R, Subhan N, Rahman MM, Jain P, Reza HM. Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome. J Lipids. 2015, Article ID 496169.Google Scholar
- Wu S-J, Ng L-T. Antioxidant and free radical scavenging activities of wild bitter melon (Momordica charantia Linn. var. abbreviata Ser.) in Taiwan. LWT - Food Sci Technol. 2008;41(2):323–30.View ArticleGoogle Scholar
- Niehaus WG, Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem. 1968;6(1):126–30.View ArticlePubMedGoogle Scholar
- Tracey WR, Tse J, Carter G. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther. 1995;272(3):1011–5.PubMedGoogle Scholar
- Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen A, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304–13.View ArticlePubMedGoogle Scholar
- Tiwari BK, Kumar D, Abidi AB, Rizvi SI. Efficacy of composite extract from leaves and fruits of medicinal plants used in traditional diabetic therapy against oxidative stress in alloxan-induced diabetic rats. ISRN Pharmacol 2014 Article ID 608590.Google Scholar
- Khan R. Protective effects of Sonchus asper (L.) Hill, (Asteraceae) against CCl4-induced oxidative stress in the thyroid tissue of rats. BMC Complement Alternat Med. 2012;12(1):181.Google Scholar
- Chance B, Maehly AC. Assay of catalase and peroxidases. Methods Enzymol. 1955;11:764.View ArticleGoogle Scholar
- Jollow D, Mitchell J, Zampaglione N, Gillette J. Bromobenzene-induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacol. 1974;11:151–69.View ArticleGoogle Scholar
- Pierce RA, Glaug MR, Greco RS, Mackenzie JW, Boyd CD, Deak SB. Increased procollagen mRNA levels in carbon tetrachloride-induced liver fibrosis in rats. J Biol Chem. 1987;262(4):1652–8.PubMedGoogle Scholar
- Khan R, Khan M, Sahreen S. CCl4-induced hepatotoxicity: protective effect of rutin on p53, CYP2E1 and the antioxidative status in rat. BMC Complement Alternat Med. 2012;12:178.View ArticleGoogle Scholar
- Fu Y, Zheng S, Lin J, Ryerse J, Chen A. Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol Pharmacol. 2008;73(2):399–409.View ArticlePubMedGoogle Scholar
- Ching RHH, Yeung LOY, Tse IMY, Sit W-H, Li ETS. Supplementation of bitter melon to rats fed a high-fructose diet during gestation and lactation ameliorates fructose-induced dyslipidemia and hepatic oxidative stress in male offspring. J Nutri. 2011;141(9):1664–72.View ArticleGoogle Scholar
- Szymonik-Lesiuk S, Czechowska G, Stryjecka-Zimmer M, Słomka M, Madro A, Celiński K, et al. Catalase, superoxide dismutase, and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication. J Hepatobiliary Pancreat Surg. 2003;10(4):309–15.View ArticlePubMedGoogle Scholar
- Bolanle JD, Adetoro KO, Balarabe SA, Adeyemi OO. Hepatocurative potential of Vitex doniana root bark, stem bark and leaves extracts against CCl4-induced liver damage in rats. Asian Pac J Trop Biomed. 2014;4(6):480–5.View ArticlePubMedPubMed CentralGoogle Scholar
- Quan J, Piao L, Wang X, Li T, Yin X. Rossicaside B protects against carbon tetrachloride-induced hepatotoxicity in mice. Basic Clin Pharmacol Toxicol. 2009;105(6):380–6.View ArticlePubMedGoogle Scholar
- Nadler EP, Dickinson EC, Beer-Stolz D, Alber SM, Watkins SC, Pratt DW, et al. Scavenging nitric oxide reduces hepatocellular injury after endotoxin challenge. Am J Physiol Gastrointest Liver Physiol. 2001;281(1):G173–81.PubMedGoogle Scholar
- Chaudhari B, Chaware V, Joshi Y, Biyani K. Hepatoprotective activity of hydroalcoholic extract of Momordica charantia Linn. leaves against carbon tetra chloride induced hepatopathy in rats. Int J ChemTech Res. 2009;1:355–8.Google Scholar
- El-Halawany AM, Dine RSE, El Sayed NS, Hattori M. Protective effect of Aframomum melegueta phenolics against CCl4-induced rat hepatocytes damage; role of Apoptosis and pro-inflammatory cytokines inhibition. Sci Rep. 2014;4:Article number: 5880.View ArticleGoogle Scholar
- Liu C, Tao Q, Sun M, Wu JZ, Yang W, Jian P, et al. Kupffer cells are associated with apoptosis, inflammation and fibrotic effects in hepatic fibrosis in rats. Lab Invest. 2010;90(12):1805–16.View ArticlePubMedGoogle Scholar
- Tung BY, Emond MJ, Bronner MP, Raaka SD, Cotler SJ, Kowdley KV. Hepatitis C, iron status, and disease severity: relationship with HFE mutations. Gastroenterol. 2003;124(2):318–26.View ArticleGoogle Scholar
- Purohit V, Russo D, Salin M. Role of iron in alcoholic liver disease: introduction and summary of the symposium. Alcohol. 2003;30(2):93–7.View ArticlePubMedGoogle Scholar
- Richards JA, Wigmore SJ, Devey LR. Heme oxygenase system in hepatic ischemia-reperfusion injury. World J Gastroenterol. 2010;16(48):6068–78.View ArticlePubMedPubMed CentralGoogle Scholar
- Immenschuh S, Baumgart-Vogt E, Mueller S. Heme oxygenase-1 and iron in liver inflammation: a complex alliance. Curr Drug Targets. 2010;11(12):1541–50.View ArticlePubMedGoogle Scholar
- Abraham NG, Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev. 2008;60(1):79–127.View ArticlePubMedGoogle Scholar
- He JY, Ge WH, Chen Y. Iron deposition and fat accumulation in dimethylnitrosamine-induced liver fibrosis in rat. World J Gastroenterol. 2007;13(14):2061–5.View ArticlePubMedPubMed CentralGoogle Scholar
- Arezzini B, Lunghi B, Lungarella G, Gardi C. Iron overload enhances the development of experimental liver cirrhosis in mice. Int J Biochem Cell Biol. 2003;35(4):486–95.View ArticlePubMedGoogle Scholar
- Houglum K, Ramm GA, Crawford DH, Witztum JL, Powell LW, Chojkier M. Excess iron induces hepatic oxidative stress and transforming growth factor beta1 in genetic hemochromatosis. Hepatol. 1997;26(3):605–10.View ArticleGoogle Scholar
- De Minicis S, Marzioni M, Saccomanno S, Rychlicki C, Agostinelli L, Trozzi L, et al. Cellular and molecular mechanisms of hepatic fibrogenesis leading to liver cancer. Transl Gastrointest Cancer. 2011;1(1):88–94.Google Scholar
- Pietrangelo AGR, Casalgrandi G, Geerts A, De Bleser P, Montosi G, Ventura E. Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. Hepatol. 1994;19(3):714–21.View ArticleGoogle Scholar
- Lee C-C, Shen S-R, Lai Y-J, Wu S-C. Rutin and quercetin, bioactive compounds from tartary buckwheat, prevent liver inflammatory injury. Food & Function. 2013;4(5):794–802.View ArticleGoogle Scholar
- Ambrose SS, Solairaj P, Subramoniam A. Effectiveness of ellagic acid on isoniazid-rifampicin induced liver damage in rats. J Pharmacol Pharmacother. 2013;4(1):60–2.View ArticlePubMedPubMed CentralGoogle Scholar
- Girish C, Pradhan SC. Drug development for liver diseases: focus on picroliv, ellagic acid and curcumin. Fund Clin Pharmacol. 2008;22(6):623–32.View ArticleGoogle Scholar
- Chang CJ, Tzeng T-F, Liou S-S, Chang Y-S, Liu I-M. Myricetin increases hepatic peroxisome proliferator-activated receptor-α, protein expression and decreases plasma lipids and adiposity in rats. Evid Based Complementary Altern Med. 2012 Article ID 787152.Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.